Share via

Leukaemia patients will be treated with genetically modified immune cells in a
pioneering British trial that could transform treatment for the disease.

Patients in the trial, which is due to begin within months, will be the first
in Europe to receive the therapy, which relies on “souping up” a patient’s
white blood cells so that they attack cancer cells.